hVIVO plc (LON:HVO – Get Free Report)’s stock price dropped 9.1% during mid-day trading on Wednesday . The company traded as low as GBX 18 ($0.22) and last traded at GBX 18.54 ($0.23). Approximately 6,675,894 shares traded hands during trading, an increase of 126% from the average daily volume of 2,957,933 shares. The stock had previously closed at GBX 20.40 ($0.25).
hVIVO Trading Up 1.6 %
The firm has a 50 day simple moving average of GBX 19.91 and a 200 day simple moving average of GBX 25.52. The firm has a market cap of £131.31 million, a P/E ratio of 643.33 and a beta of 0.97. The company has a debt-to-equity ratio of 33.86, a quick ratio of 1.16 and a current ratio of 1.61.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Featured Stories
- Five stocks we like better than hVIVO
- What is Put Option Volume?
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Investing in the High PE Growth Stocks
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
